The primary goal of this study was to test a hypothesis that an internalization of Ec1/EpCAM complex by ovarian cancer cells is slow enough to permit imaging of tumors using [125I]I-PIB-Ec1 a few hours after injection. Here, EPCAM is linked to ovarian cancer.